Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START study - Top-Institutions - MDSpire

Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START study

  • By

  • Nila J Dharan

  • Shweta Sharma

  • Alejandro Arenas-Pinto

  • Daniel Duprez

  • Vicente Estrada

  • Karen Ha

  • Mariana Angelica Kundro

  • Rosie Mngqibisa

  • Henry Mugerwa

  • David Munroe

  • Rakan Nasreddine

  • Tess E Peterson

  • Irini Sereti

  • Janine M Trevillyan

  • Jason V Baker

  • Gail V Matthews

  • Andrew N Phillips

  • for the INSIGHT START Study Group

  • September 15, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, MD

    Key Differentiators

    • Infectious Diseases
    • HIV Research
    • Cardiovascular Epidemiology

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Cardiology
    • Epidemiology

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Cardiology
    • Clinical Research

  • #4

    Massachusetts General Hospital (MGH) / Harvard Medical School
    Massachusetts General Hospital (MGH) / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Cardiology
    • Epidemiology

  • #5

    University of North Carolina at Chapel Hill
    University of North Carolina at Chapel Hill

    Chapel Hill, NC

    Key Differentiators

    • Infectious Diseases
    • Cardiology
    • Population Health

Original Source(s)

Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START study

  • by Nila J Dharan, Shweta Sharma, Alejandro Arenas-Pinto, Daniel Duprez, Vicente Estrada, Karen Ha, Mariana Angelica Kundro, Rosie Mngqibisa, Henry Mugerwa, David Munroe, Rakan Nasreddine, Tess E Peterson, Irini Sereti, Janine M Trevillyan, Jason V Baker, Gail V Matthews, Andrew N Phillips, for the INSIGHT START Study Group

  • September 15, 2025

Related Content

Periodontal Disease and ASCVD: Updated

AHA Scientific Statement examines the association between periodontal disease and atherosclerotic cardiovascular disease

AI Falls Short on Differential Dx

New PrIME-LLM benchmark shows strong diagnostic accuracy but persistent gaps in clinical reasoning across 21 large language models

Smell Screening With a Mobile Test

Researchers evaluated a rapid, self-administered mobile application–based test designed to screen for olfactory dysfunction in adult participants.